 | ACADIA Pharmaceuticals (NASDAQ:ACAD) Rating Increased to C- at TheStreet marketbeat.com - February 26 at 7:08 AM |
 | Analysts Anticipate ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Announce -$0.60 EPS americanbankingnews.com - March 7 at 8:10 PM |
 | ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Up 6.9% americanbankingnews.com - March 5 at 7:33 PM |
 | ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Increased to $65.00 by Analysts at Morgan Stanley americanbankingnews.com - March 3 at 10:22 AM |
 | ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Down 5.3% americanbankingnews.com - March 2 at 7:02 PM |
 | ACADIA Pharmaceuticals (NASDAQ:ACAD) PT Raised to $63.00 americanbankingnews.com - March 2 at 10:02 AM |
 | Equities Analysts Offer Predictions for ACADIA Pharmaceuticals Inc.'s Q1 2021 Earnings (NASDAQ:ACAD) americanbankingnews.com - March 1 at 2:28 AM |
 | ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Expected to Post Q1 2021 Earnings of ($0.58) Per Share americanbankingnews.com - March 1 at 2:28 AM |
 | ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Just Released Its Full-Year Results And Analysts Are Updating Their Estimates nasdaq.com - March 1 at 1:06 AM |
 | Morgan Stanley Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $65 benzinga.com - February 26 at 10:23 AM |
|
 | ACADIA Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 sales results. benzinga.com - February 26 at 10:23 AM |
 | ACADIA Pharmaceuticals' (ACAD) "Overweight" Rating Reaffirmed at Morgan Stanley americanbankingnews.com - February 25 at 10:09 AM |
 | ACADIA Pharmaceuticals Inc. 2020 Q4 - Results - Earnings Call Presentation seekingalpha.com - February 25 at 4:10 AM |
 | ACADIA Pharmaceuticals (NASDAQ:ACAD) Receives "Buy" Rating from Mizuho americanbankingnews.com - February 25 at 1:02 AM |
 | Acadia Pharmaceuticals (ACAD) Reports Q4 Loss, Lags Revenue Estimates nasdaq.com - February 24 at 8:18 PM |
 | Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results finance.yahoo.com - February 24 at 8:18 PM |
 | Recap: ACADIA Pharmaceuticals Q4 Earnings finance.yahoo.com - February 24 at 8:18 PM |
 | Glaucoma Pharmaceuticals Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025 marketwatch.com - February 23 at 10:35 PM |
 | A Preview Of ACADIA Pharmaceuticals's Earnings benzinga.com - February 23 at 12:33 PM |
 | Announcing: ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Increased An Energizing 191% In The Last Five Years finance.yahoo.com - February 23 at 7:33 AM |
 | Acadia Pharmaceuticals Recognizes National Caregiver’s Day with Launch of MoreThanMemoryLoss.com finance.yahoo.com - February 19 at 12:31 PM |
 | Interesting ACAD Put And Call Options For April 1st nasdaq.com - February 11 at 6:27 PM |
 | Trade Alert: The CEO & Director Of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Stephen Davis, Has Sold Some Shares Recently nasdaq.com - February 10 at 7:59 AM |
 | Glaucoma Pharmaceuticals Market Analysis, Trends, Growth, Size, Share and Forecast 2019 to 2025 marketwatch.com - February 9 at 8:19 AM |
 | Glaucoma Pharmaceuticals Market Size By Regional Industry Growth, Statistics And Forecast marketwatch.com - February 1 at 1:42 PM |
 | Acadia Pharmaceuticals Announces Commercial Leadership Change finance.yahoo.com - January 27 at 6:07 PM |
 | Interesting ACAD Put And Call Options For April 16th nasdaq.com - January 6 at 1:40 PM |
 | Interesting ACAD Put And Call Options For February 2021 nasdaq.com - December 18 at 1:18 PM |
 | Mizuho Initiates Coverage On ACADIA Pharmaceuticals with Buy Rating, Announces Price Target of $69 benzinga.com - December 17 at 7:35 PM |
 | Morgan Stanley Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $60 benzinga.com - December 17 at 7:35 PM |
|
 | Is ACAD A Good Stock To Buy Now? finance.yahoo.com - December 15 at 3:02 PM |
 | Glaucoma Pharmaceuticals Market Research Analysis and Competitive Analysis 2020 to 2025 With Impact of Covid-19 marketwatch.com - December 9 at 7:28 AM |
 | Why Is Acadia (ACAD) Up 9.7% Since Last Earnings Report? finance.yahoo.com - December 4 at 4:29 PM |
 | ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Shift From Loss To Profit finance.yahoo.com - November 25 at 7:15 AM |
 | Parkinson's Dyskinesia Market Size Report 2020 Global Industry Analysis by Trends, Revenue, Share, Revenue and Forecast to 2025 marketwatch.com - November 21 at 2:40 PM |
 | Glaucoma Pharmaceuticals Market Analysis, Innovation Trends and Current Business Trends by 2025 marketwatch.com - November 20 at 6:39 PM |
 | ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 2020 Stifel Virtual Healthcare Conference (Transcript) seekingalpha.com - November 18 at 6:23 PM |
 | Alzheimer’s Therapeutic Market 2020 Trends, Key Players, Manufacturers Data, Price Analysis, Company Profiling By Type, By Density Composition marketwatch.com - November 10 at 3:52 AM |
 | What's Behind Acadia Pharmaceuticals' Mixed Q3 Results finance.yahoo.com - November 5 at 1:12 PM |
 | ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Steve Davis on Q3 2020 Results - Earnings Call Transcript seekingalpha.com - November 5 at 12:30 AM |
 | Acadia Pharmaceuticals Reports Third Quarter 2020 Financial Results finance.yahoo.com - November 4 at 7:29 PM |
 | Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com - November 4 at 7:29 PM |
 | Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials bloomberg.com - October 27 at 6:07 AM |
 | Were Hedge Funds Wrong About Embracing ACADIA Pharmaceuticals Inc. (ACAD)? finance.yahoo.com - October 26 at 10:34 PM |
 | Acadia Pharmaceuticals fool.com - October 24 at 6:27 PM |
 | The Schizophrenia market is expected to increase with a CAGR of 6.89% for the study period 2017-2030 in the 7MM, estimates DelveInsight prnewswire.com - October 21 at 2:05 PM |
 | The Lewy Body Dementia Association and Acadia Pharmaceuticals to Release Educational Version of the Highly Acclaimed Robin Williams Documentary, “Robin’s Wish” businesswire.com - October 14 at 6:42 PM |
 | Glaucoma Pharmaceuticals Market 2020 Share, Size, Regional Trend, Top Manufacturers, Future Growth, Types and Applications, Forecast to 2026 marketwatch.com - September 15 at 12:30 PM |
 | ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript) seekingalpha.com - September 14 at 8:38 PM |
 | Acadia (ACAD) Down 12% Since Last Earnings Report: Can It Rebound? finance.yahoo.com - September 4 at 2:42 PM |
 | ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences finance.yahoo.com - September 2 at 12:28 PM |